OncoCyte Corporation (OCX) has seen some recent movement in the marketplace and its shares closed trading at $3.4500 yesterday. People are starting to take interest of OCX as the shares traded as high as $3.5100 and as low as $3.1800 in the prior market trading session.

OncoCyte Corporation (OCX) average trading volume is 379.60K. However, in the prior market trading session OncoCyte Corporation (OCX) exchanged 1,220,619 shares. The 1st downside support level on OCX is $3.26. OCX 50-day moving average is $2.7309 and OCX two hundred day moving average is $2.4586.

OncoCyte Corporation (OCX) recent performance has been specified by the recent movement in OCX shares. OCX has performed 26.37% over the past 30 days, OCX has performed 62.74% over the past 90 days and OCX has shown 36.90% over the past 365 days. OncoCyte Corporation (OCX) has a 12 month range of $1.5000 to $3.5100. OncoCyte Corporation (OCX) is trading 130.00% from its 12 month low and -14.81% from its 12 month high. OncoCyte Corporation (OCX) is indicating a 2.14% short float indicating the quantity short in the float.

OCX has 61.46M shares outstanding and 54.91M shares in the float. OncoCyte Corporation (OCX) currently has a market cap of $207.69M and income of -26.30M. The EPS next quarter for OCX is -0.10 and projected EPS next year is 11.60%. The market cap of OncoCyte Corporation (OCX) at $207.69M represents how many People own shares of OCX and is based off the last price ($3.4500) of OCX and the quantity of shares outstanding (61.46M) with OncoCyte Corporation (OCX).

OncoCyte Corporation (OCX) has aggregate cash (mrq) of 16.9M, aggregate cash per share (mrq) of 0.25, aggregate debt of OCX rests at 6.54M and aggregate debt/equity (mrq) is 17.84. . OncoCyte Corporation (OCX) running cash flow (ttm) is -19.87M, OCX leveraged free cash flow (ttm) is -10.43M.

OCX is trading 29.07% above (bullish) its SMA20, 32.55% above (bullish) its SMA50 and 53.86% above (bullish) its SMA200.